Cargando…
Treatment of Uterine Myoma with 2.5 or 5 mg Mifepristone Daily during 3 Months with 9 Months Posttreatment Followup: Randomized Clinical Trial
Objectives. To evaluate the efficacy, safety, and quality of life by using 2.5 and mifepristone 5 mg daily doses to treat uterine fibroids over 3 months with a 9-month followup period. Design. Randomized clinical trial. Place. “Eusebio Hernández” Hospital, Havana, Cuba. Subjects. 220 women with symp...
Autores principales: | Carbonell, Josep Lluis, Acosta, Rita, Pérez, Yasmirian, Garcés, Roberto, Sánchez, Carlos, Tomasi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747426/ https://www.ncbi.nlm.nih.gov/pubmed/23984082 http://dx.doi.org/10.1155/2013/649030 |
Ejemplares similares
-
Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial
por: Esteve, Josep Lluis Carbonell, et al.
Publicado: (2013) -
Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery
por: Carbonell Esteve, Josep L, et al.
Publicado: (2012) -
Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman
por: Seth, Shikha, et al.
Publicado: (2013) -
Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial
por: Carbonell, Josep Lluis, et al.
Publicado: (2015) -
Safety and effectiveness of different dosage of mifepristone for the treatment of uterine fibroids: a double-blind randomized clinical trial
por: Carbonell, Josep LL, et al.
Publicado: (2013)